Hologic Inc
(BSP:H1OL34)
R$
447.04
0 (0%)
Market Cap: 103.83 Bil
Enterprise Value: 105.01 Bil
PE Ratio: 23.66
PB Ratio: 3.57
GF Score: 87/100 Hologic Inc at RBC Capital Markets Healthcare Conference Transcript
May 21, 2019 / 12:30PM GMT
Brandon Christopher Henry
RBC Capital Markets, LLC, Research Division - Analyst
We're going to start next session. My name is Brandon Henry, and I'm the medical device analyst here at RBC. On stage with me is Mike Watts, VP of Investor Relations and Corporate Communication. So Mike, thank you for joining us.
Michael J. Watts
Hologic, Inc. - VP of IR & Corporate Communications
Thanks for having us.
Brandon Christopher Henry
RBC Capital Markets, LLC, Research Division - Analyst
I think you wanted to start out with a brief kind of 2, 3 minute introduction and then we'll jump into Q&A.
Michael J. Watts
Hologic, Inc. - VP of IR & Corporate Communications
Yes, Sure. So thanks to you and to RBC for hosting us. We appreciate it. Do see some new faces in the room, so let me spend a couple of minutes and just give a brief overview of Hologic to level set us. We are an innovative medical device company. We're primarily focused on improving women's health through
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot